Retrospective Analysis for Patients With Metabolic Syndrome

NCT06182618 · Unknown status

Last updated 2026-05-28

This study looked back at medical records to examine how patients with metabolic syndrome were treated and what their weight outcomes were.

Status Unknown status The sponsor has not confirmed the status recently.

Type Observational

Participants 400 people Planned (estimated).

Who can join Ages 18–65 · all sexes Healthy volunteers accepted.

Timeline Started 2023-06 · est. completion 2024-01

Where 1 site · China

What this study is testing ClinicalTrials.gov NCT06182618 ↗

Description as written by the study sponsor.

The incidence of metabolic syndrome and related diseases is gradually increasing, and diet and medication are currently common outpatient treatment methods. This study retrospectively analyzes the clinical data of patients with metabolic syndrome and related diseases who have visited our outpatient department in the past 10 years, compares the therapeutic effects of different treatment methods on their blood glucose, blood lipids, blood pressure, uric acid, and body composition, and provides evidence support for clinical treatment.

Treatments tested

dietary, semaglutide or/and metformin Other

patients were prescribed dietary and pharmaceuticals for weight loss

Main thing measured	weight
Sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions studied	Metabolic Syndrome
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06182618 ↗